Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: glycerol; hydrochloric acid; water for injections - south africa: acute non-lymphocytic leukaemia (anll), including acute myeloblastic leukaemia (aml) in adults, for remission induction as front-line therapy, or for remission induction in relapsed or refractory patients. zavedos, in combination with cytarabine, is indicated for the first remission induction-line treatment of previously untreated children with acute myeloid leukaemia (aml)

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: glycerol; hydrochloric acid; water for injections - south africa: acute non-lymphocytic leukaemia (anll), including acute myeloblastic leukaemia (aml) in adults, for remission induction as front-line therapy, or for remission induction in relapsed or refractory patients. zavedos, in combination with cytarabine, is indicated for the first remission induction-line treatment of previously untreated children with acute myeloid leukaemia (aml)

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - acute myeloid leukaemia in combination with other cytotoxic agents. acute lymphoblastic leukaemia as a reserve medicinal product in combination with other cytotoxic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - taiwan acute non-lymphatic leukaemia (anll) in adults. acute lymphatic leukaemia (all) in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - brunei darussalam and malaysia: antimitotic and cytotoxic agent. acute non-lymphocytic leukemia (anll) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. acute lymphocytic leukemia (all) as second line treatment in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - zavedos is used to treat acute myeloid and lymphoid leukaemia (types of blood cancer) in adults and children. zavedos may be administered as a monotherapy or as part of combination therapy (with cytarabine).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - uk: zavedos is used in adults and children for the treatment of acute non lymphoblastic leukaemia (anll), also referred to as acute myeloid leukaemia (aml). zavedos is also used in adults and children as a second line treatment of relapsed acute lymphoblastic leukaemia (all)

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - idarubicin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - idarubicin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - idarubicin hydrochloride -